To assess the effect of B cell-specific EPO-R signaling on bone mass, we created a murine model of a conditional EPO-R knockdown (cKD) in the B cell lineage, where the Cre-recombinase activity is driven by the MB1 promoter (MB1-Cre;EPO-Rfl/fl) 47. This evidence concerns the gene EPO and chronic kidney disease.